Pathogenic BRCA2 germline variants in combined hepatocellular-cholangiocarcinoma

Pathol Int. 2022 Feb;72(2):138-140. doi: 10.1111/pin.13188. Epub 2021 Nov 22.

Authors

Hongjie Li^{1

2}, Xuchen Zhang², Karin E Finberg², Zenta Walther², Dhanpat Jain², Joanna Gibson²

Affiliations

¹ Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.
² Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.

PMID: 34808016
DOI: 10.1111/pin.13188

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
BRCA2 Protein / genetics*
Carcinoma, Hepatocellular / genetics*
Carcinoma, Hepatocellular / pathology
Cholangiocarcinoma / genetics*
Cholangiocarcinoma / pathology
Female
Germ-Line Mutation
Humans
Liver Neoplasms / genetics*
Liver Neoplasms / pathology
Loss of Heterozygosity
Male
Middle Aged

Substances

BRCA2 Protein
BRCA2 protein, human